Guido Böning

2.6k total citations
74 papers, 1.8k citations indexed

About

Guido Böning is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Guido Böning has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Pulmonary and Respiratory Medicine and 13 papers in Radiation. Recurrent topics in Guido Böning's work include Medical Imaging Techniques and Applications (35 papers), Radiopharmaceutical Chemistry and Applications (29 papers) and Prostate Cancer Treatment and Research (19 papers). Guido Böning is often cited by papers focused on Medical Imaging Techniques and Applications (35 papers), Radiopharmaceutical Chemistry and Applications (29 papers) and Prostate Cancer Treatment and Research (19 papers). Guido Böning collaborates with scholars based in Germany, Canada and United States. Guido Böning's co-authors include Peter Bartenstein, Franz Josef Gildehaus, Astrid Gosewisch, Harun Ilhan, Christian G. Stief, Andreas Delker, Sibylle Ziegler, Wolfgang P. Fendler, Andrei Todica and Marcus Unterrainer and has published in prestigious journals such as NeuroImage, Physics in Medicine and Biology and Molecular Therapy.

In The Last Decade

Guido Böning

69 papers receiving 1.8k citations

Peers

Countries citing papers authored by Guido Böning

Since Specialization

Citations

This map shows the geographic impact of Guido Böning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Böning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Böning more than expected).

Fields of papers citing papers by Guido Böning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Böning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Böning. The network helps show where Guido Böning may publish in the future.

Co-authorship network of co-authors of Guido Böning

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Böning. A scholar is included among the top collaborators of Guido Böning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Böning. Guido Böning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic Efficacy of 123Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies 2024 ·Diagnostics ·(unknown), Maximilian Scheifele, Mathias J. Zacherl, Sabrina Katzdobler, Alexander Bernhardt, (unknown), Johannes Levin, Günter U. Höglinger, Sebastian Clauß, Stefan Kääb, Andrei Todica, Guido Böning, Maximilian Fischer	1
2	Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [¹⁷⁷Lu]Lu-PSMA-I&T Therapy 2024 ·Journal of Nuclear Medicine ·(unknown), Sibylle Ziegler, (unknown), Lena M. Unterrainer, Mathias J. Zacherl, Peter Bartenstein, Guido Böning, Julia Brosch-Lenz, (unknown)	2
3	Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition 2023 ·EJNMMI Physics ·(unknown), (unknown), Mathias J. Zacherl, (unknown), (unknown), (unknown), Lena M. Unterrainer, Vera Wenter, Peter Bartenstein, Sibylle Ziegler, Harun Ilhan, Leonie Beyer, Guido Böning, (unknown)	14
4	Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS 2023 ·EJNMMI Physics ·(unknown), Wei Bo Li, Simon Lindner, (unknown), (unknown), Peter Bartenstein, Sibylle Ziegler, Guido Böning, (unknown)	7
5	First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study 2023 ·EJNMMI Research ·Wolfgang Roll, Michael Müther, Guido Böning, (unknown), Nils Warneke, Franz‐Josef Gildehaus, Michael Schäfers, Walter Stummer, Reinhard Zeidler, Hans‐Jürgen Reulen, Lars Stegger	6
6	Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse model 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Katja Steiger, Simon Lindner, (unknown), Kirsten Lauber, Nikko Brix, Barbara von Ungern‐Sternberg, (unknown), Giovanna Palumbo, Guido Böning, Simone Schüle, Matthäus Majewski, Matthias Port, Sibylle Ziegler, Peter Bartenstein	1
7	Feasibility of single-time-point dosimetry for radiopharmaceutical therapies 2020 ·Journal of Nuclear Medicine ·Xinchi Hou, Julia Brosch-Lenz, Carlos Uribe, (unknown), Guido Böning, Jean‐Mathieu Beauregard, A. Ćeller, Arman Rahmim	44
8	First Clinical Results for PSMA-Targeted α-Therapy Using ²²⁵Ac-PSMA-I&T in Advanced-mCRPC Patients 2020 ·Journal of Nuclear Medicine ·Mathias J. Zacherl, Franz Josef Gildehaus, Lena M. Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina-Sophie Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Peter Bartenstein, Andrei Todica, Harun Ilhan	129
9	Response to 225Ac-PSMA-I&T after failure of long-term 177Lu-PSMA RLT in mCRPC 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Harun Ilhan, Astrid Gosewisch, Guido Böning, (unknown), Mathias J. Zacherl, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Franz Josef Gildehaus	19
10	Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival 2019 ·BMC Cancer ·(unknown), Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Guido Böning, Franz Josef Gildehaus, Wolfgang P. Fendler, Christoph J. Auernhammer, Christine Spitzweg, Peter Bartenstein, Andrei Todica, Harun Ilhan	60
11	3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT 2019 ·EJNMMI Research ·Astrid Gosewisch, Harun Ilhan, (unknown), Andrea Mairani, Katia Parodi, Julia Brosch-Lenz, Lena Kaiser, Franz Josef Gildehaus, Andrei Todica, Sibylle Ziegler, Peter Bartenstein, Guido Böning	29
12	TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marcus Unterrainer, Christoph Mahler, Lena Vomacka, Simon Lindner, Joachim Havla, Matthias Brendel, Guido Böning, Birgit Ertl‐Wagner, Tania Kümpfel, Vladimir M. Milenkovic, Rainer Rupprecht, Martin Kerschensteiner, Peter Bartenstein, Nathalie L. Albert	47
13	Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation 2018 ·EJNMMI Research ·Lena Vomacka, Marcus Unterrainer, Adrien Holzgreve, Erik Mille, Astrid Gosewisch, Julia Brosch-Lenz, Sibylle Ziegler, Bogdana Suchorska, Friedrich-Wilhelm Kreth, Jörg‐Christian Tonn, Peter Bartenstein, Nathalie L. Albert, Guido Böning	17
14	Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach 2018 ·EJNMMI Research ·Astrid Gosewisch, Andreas Delker, (unknown), Harun Ilhan, Andrei Todica, Julia Brosch-Lenz, Lena Vomacka, Anika Brunegraf, Franz Josef Gildehaus, Sibylle Ziegler, Peter Bartenstein, Guido Böning	26
15	O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres 2017 ·EJNMMI Research ·Christian Filß, Nathalie L. Albert, Guido Böning, Elena Rota Kops, Bogdana Suchorska, Gabriele Stoffels, Norbert Galldiks, N. Jon Shah, Felix M. Mottaghy, Peter Bartenstein, Jörg C. Tonn, Karl‐Josef Langen	13
16	Monitoring of Tumor Growth with [18F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches 2016 ·Frontiers in Neuroscience ·Adrien Holzgreve, Matthias Brendel, Song Gu, Janette Carlsen, Erik Mille, Guido Böning, (unknown), Marcus Unterrainer, F.J. Gildehaus, Axel Rominger, Peter Bartenstein, Roland E. Kälin, Rainer Glaß, Nathalie L. Albert	9
17	Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Andreas Delker, Wolfgang P. Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian G. Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein, Guido Böning	239
18	Dose-Dependent Uptake of 3′-deoxy-3′-[18 F]Fluorothymidine by the Bowel after Total-Body Irradiation 2014 ·Molecular Imaging and Biology ·Markus Hartenbach, Andreas Delker, Sabrina Hartenbach, Juli Schlichtiger, Sabrina Niedermoser, Carmen Wängler, Björn Wängler, Guido Böning, Franz Josef Gildehaus, Klement Neumaier, Kirsten Lauber, K. Kraft, Claus Belka, Marcus Hacker, Viktor Meineke, Peter Bartenstein	1
19	In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and ¹⁸F-Fallypride 2014 ·Journal of Nuclear Medicine ·Veronika Schönitzer, Florian Haasters, (unknown), (unknown), Erik Mille, Franz Josef Gildehaus, Janette Carlsen, (unknown), Roswitha Beck, Andreas Delker, Guido Böning, W. Mutschler, Wolfgang Böcker, Matthias Schieker, Peter Bartenstein	18
20	Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [18F]-florbetaben PET 2013 ·NeuroImage ·Matthias Brendel, Andreas Delker, (unknown), Guido Böning, Janette Carlsen, Clemens C. Cyran, Erik Mille, Franz Josef Gildehaus, Paul Cumming, Karlheinz Baumann, Harald Steiner, Christian Haass, Jochen Herms, Peter Bartenstein, Axel Rominger	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact